Founded in 2023 by Dr. Brandon M. Henry, EvGenTx is an independent, non-commercial, physician-led translational research lab dedicated to advancing safety science, evidence generation, and clinical methodology in the rapidly evolving fields of cell, gene, and RNA therapy.

EvGenTx reflects Dr. Henry’s personal commitment to strengthening the scientific and methodological foundations of genetic medicine through rigorous, data-driven inquiry. The lab’s work bridges clinical, translational, and regulatory domains—conducting guideline development, systematic reviews, meta-analyses, and translational/clinical research projects that critically evaluate or advance the safety, efficacy, and methodological rigor of emerging genetic therapeutics. By integrating quantitative and qualitative evidence with translational insight, EvGenTx aims to inform clinical and regulatory decision-making, advance best practices, and contribute to the responsible evolution of the gene therapy field.

Through this work, EvGenTx Lab seeks to advance the practice of evidence-based medicine for genetic therapeutics, bridging discovery and real-world impact to ultimately improve outcomes for patients worldwide.